Neuroleptic malignant syndrome after 30 years treatment with clozapine: A rarely seen differential diagnosis on intensive care units;Malignes neuroleptisches syndrom nach 30-jähriger behandlung mit clozapin: Eine seltene differenzial-diagnose auf der intensivstation

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 41, Issue 2, 2006, Pages 125-127

  Franzen, Daniel ^a,b   Burkhard, J ^a   Corti, N ^c   Schupbach D ^d   Fontanel, D ^e   Staubli M ^a  

^a Medizinische Klinik Zurich   (Switzerland)

^b Spital Zollikerberg   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^e Medizinische Klinik Winterthur   (Switzerland)

Author keywords

Catatonia; Clozapine; Hyperthermia; Neuroleptic malignant syndrome; Rhabdomyolysis

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; CREATINE KINASE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; CASE REPORT; CATATONIA; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERTHERMIA; INTENSIVE CARE UNIT; LEUKOCYTOSIS; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; RHABDOMYOLYSIS; STUPOR;

ANTIPSYCHOTIC AGENTS; BODY TEMPERATURE; CLOZAPINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; RHABDOMYOLYSIS; SCHIZOPHRENIA;

EID: 33644770095     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-921089     Document Type: Article

References (16)

1. Arzneimittelkompendium der Schweiz 2005. Basel: Documed 2005, www.kompendium.ch
2. Miller DD. Review and management of clozapine side effects. J Clin Psychiatry 2000; 61 (Suppl 8): 14-17
3. Karagianis JL, Phillips LC, Hogan KP, LeDrew KK. Clozapine - associated neuroleptic malignant syndrome: two new cases and a review of the literature. Ann Pharmacother 1999; 33: 623-623
4. Redding S, Minnema AM, Tandon R. Neuroleptic malignant syndrome and clozapine. Ann Clin Psychiatry 1993; 5: 25-27
5. Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 2004; 65: 1722-1723
6. Spivak B, Maline DI, Kozyrev VN, Mester R, Neduva SA, Ravilov RS, Weizman A. Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow. Eur Psychiatry 2000; 15: 330-333
7. Gönner F, Baumgartner R, Schüpbach D, Merlo MCG. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report. Psychopharmacol 1999; 144: 416-418
8. Hall RC, Appleby B, Hall RC. Atypical neuroleptic malignant syndrome presenting as fever of unknown origin in the elderly. South Med J. 2005; 98: 114-117
9. Pandya M, Pozuelo L. A malignant neuroleptic spectrum: review of diagnostic criteria and treatment implications in three case reports. Int J Psychiatry Med. 2004; 34: 277-285
10. Diagnostic and statistical manual of mental disorders, 4th ed - Primary care version. Arlington: American Psychiatric Association, 1995
11. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137-1145
12. Bhanushali MJ, Tuite PJ. The Evaluation and management of patients with neuroleptic malignant syndrome. Neurol Clin 2004; 22: 389-411
13. Pietzcker A. Das maligne neuroleptische Syndrom. Nervenarzt 1988; 59: 691-700
14. Scelsa SN, Simpson DM, McQuistion HL, Findeman A, Ault K, Reichler B. Clozapine-induced myotoxicity in patients with chronic psychotic disorders. Neurology 1996; 47: 1518-1523
15. Hasan S, Buckley P. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. Am J Psychiatry 1998; 155: 1113-1116
16. Huang TL. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallange. Chang Gung Med J 2001; 24: 522-525